# LAMIVUDINE; STAVUDINE; NEVIRAPINE
> **NDA021969** · New Drug Application · Sponsor: CIPLA LIMITED · Approved 2006-11-17
## Drug
- **FDA Application Number:** NDA021969
- **Application type:** New Drug Application
- **Brand name:** LAMIVUDINE; STAVUDINE; NEVIRAPINE
- **Generic name:** Lamivudine
- **Active ingredients:** LAMIVUDINE; STAVUDINE; NEVIRAPINE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** CIPLA LIMITED
- **First approval:** 2006-11-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021969)
---
*MORVS · CC0 1.0*